Naltrexone implant for alcohol use disorder
Treatments studied
Part of Mental health clinical trials.
This trial tests a naltrexone implant designed to help people with moderate to severe alcohol use disorder cut down on drinking. The implant slowly releases medication for several months, so you don't have to remember to take a pill every day.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have moderate to severe alcohol use disorder (at least 4 out of 11 DSM-5 criteria).
- You cannot be pregnant, breastfeeding, or planning to become pregnant during the study.
- You must not have a serious liver condition (liver failure or very high liver enzymes).
- You must not have had a drug problem (other than alcohol or tobacco) in the past year.
- You cannot be currently taking medications like naltrexone or receiving counseling for drinking.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.
This trial tests if tirzepatide, a medication that helps with appetite and blood sugar, can help people with alcohol use disorder drink less or stop drinking. You would visit the clinic regularly and receive the drug or a placebo.
This Phase 4 study tests whether naltrexone injections can help people with alcohol use disorder (AUD) reduce or stop heavy drinking. You may get two injections over 8 weeks, and you can join if you meet specific drinking pattern and eligibility rules.
This trial compares two forms of naltrexone (a medication used for alcohol and opioid dependence) in healthy volunteers. It tests how well the body processes and tolerates a low or high-dose implant versus the standard monthly injection.
This Phase 2 study tests whether a long-acting naltrexone implant can help people with opioid use disorder stay away from opioid relapse. You may get the implant after safely finishing opioid withdrawal and stopping other naltrexone dosing at the right time.
This study tests a new implant (BICX104) with or without bupropion to see how safe it is and how it works in the body, compared to an existing treatment (Vivitrol). If you are healthy and not using opioids, you may be eligible to help researchers understand if this implant could be a new option for treatment.
Hear when a new Alcohol Use Disorder (AUD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.